Contact this trialFirst, we need to learn more about you.
Kinase Inhibitor
Trametinib for Hormone-Resistant Prostate Cancer
Recruiting1 awardPhase 2
Los Angeles, California
This trial studies how well trametinib works in patients with advanced prostate cancer that has not responded to typical hormone treatments. Trametinib aims to stop cancer cells from growing by blocking essential enzymes.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service